+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Canine Arthritis Market by Product Type, Route of Administration, End User, Therapy Type - Global Forecast 2025-2030- Product Image
Canine Arthritis Market by Product Type, Route of Administration, End User, Therapy Type - Global Forecast 2025-2030- Product Image
Sale

Canine Arthritis Market by Product Type, Route of Administration, End User, Therapy Type - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 191 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 6010632
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Canine Arthritis Market grew from USD 1.81 billion in 2023 to USD 1.92 billion in 2024. It is expected to continue growing at a CAGR of 7.88%, reaching USD 3.08 billion by 2030.

Canine arthritis is a prevalent condition marked by the inflammation of joints in dogs, leading to pain and reduced mobility akin to arthritis in humans. As the pet population grows, particularly among aging dogs, the market for canine arthritis treatments is expanding. The necessity for effective solutions arises from increasing pet ownership and awareness about pet health, driving demand for therapeutic options like NSAIDs, physical therapy, nutritional supplements, and innovative treatments such as stem cell therapy. The application and end-use scope encompass veterinary clinics, animal hospitals, and home care settings, driven by pet owners' increasing willingness to invest in pets' quality of life. Market growth is fueled by advances in veterinary medicine, rising disposable incomes facilitating pet healthcare expenditures, and enhanced diagnostic capabilities for early detection of arthritis. Key growth opportunities include the development of novel therapeutics, increased research into genetic predispositions, and holistic treatment approaches integrating lifestyle and dietary changes. Conversely, limitations such as high treatment costs, potential side effects of long-term medication use, and lack of awareness in developing regions pose challenges. Product safety and efficacy remain pivotal, necessitating stringent regulatory pathways that may slow market entry for novel therapies. The market displays a competitive yet fragmented nature, with opportunities for collaboration between pharmaceutical companies and veterinary specialists. Innovations like personalized medicine and smart devices for continuous monitoring offer exciting prospects for growth. Focusing on research that targets disease-modifying therapies, rather than symptom control alone, represents a promising area for breakthroughs. Adopting an integrated treatment protocol encompassing various modalities can enhance market penetration. Overall, the market for canine arthritis solutions presents robust potential, with strategic investments in research and education seen as crucial for capitalizing on emerging trends and overcoming current market barriers.

Understanding Market Dynamics in the Canine Arthritis Market

The Canine Arthritis Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Increasing prevalence of arthritis among the global canine population due to aging pets and lifestyle
    • Innovations in veterinary medicine and treatments for managing canine arthritis effectively
    • Growing awareness and pet owner's willingness to spend on canine health and wellness
    • Advancements in diagnostic techniques leading to early detection and treatment of arthritis in dogs
  • Market Restraints
    • Insufficient number of specialized veterinary professionals to adequately address canine arthritis cases
    • Regulatory challenges affecting the approval and availability of novel treatments for canine arthritis
  • Market Opportunities
    • Specialized canine arthritis treatment centers offering holistic and integrative medical approaches
    • Subscription-based delivery of joint supplements and pain relief medications for arthritic dogs
    • Wearable technology for continuous monitoring and management of arthritis symptoms in dogs
  • Market Challenges
    • High costs associated with veterinary care and arthritis treatments leading to reduced market accessibility
    • Lack of awareness and education among pet owners about early signs and preventive care for canine arthritis

Exploring Porter’s Five Forces for the Canine Arthritis Market

Porter’s Five Forces framework further strengthens the insights of the Canine Arthritis Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Canine Arthritis Market

External macro-environmental factors deeply influence the performance of the Canine Arthritis Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Canine Arthritis Market

The Canine Arthritis Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Canine Arthritis Market

The Canine Arthritis Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Canine Arthritis Market

The Canine Arthritis Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Canine Arthritis Market, highlighting leading vendors and their innovative profiles. These include Bayer AG, Boehringer Ingelheim International GmbH, Ceva Santé Animale, Dechra Pharmaceuticals PLC, Elanco Animal Health Incorporated, Merck Animal Health, Nutramax Laboratories, Inc., Vetoquinol S.A., Virbac, and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Canine Arthritis Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Product Type
    • Assistive Devices and Joint Support
      • Braces
      • Harnesses
      • Other Assistive Devices
    • Disease-Modifying Osteoarthritis Drugs (DMOADs)
      • Structure-Modifying DMOADs
      • Symptomatic DMOADs
    • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
      • Over-the-Counter NSAIDs
      • Prescription NSAIDs
    • Pain Management Drugs
      • Opioids
      • Other Pain Management Drugs
      • Steroids
    • Surgical Treatments
      • Arthroscopic Surgery
      • Joint Replacement Surgery
      • Other Surgical Treatments
  • Route of Administration
    • Injectable
    • Oral
    • Topical
  • End User
    • Online Pharmacies
    • Retail Pharmacies
    • Veterinary Hospitals and Clinics
  • Therapy Type
    • Drug Therapy
    • Physical Therapy
      • Acupuncture
      • Hydrotherapy
      • Laser Therapy
      • Other Physical Therapies
    • Surgical Therapy
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of arthritis among the global canine population due to aging pets and lifestyle
5.1.1.2. Innovations in veterinary medicine and treatments for managing canine arthritis effectively
5.1.1.3. Growing awareness and pet owner's willingness to spend on canine health and wellness
5.1.1.4. Advancements in diagnostic techniques leading to early detection and treatment of arthritis in dogs
5.1.2. Restraints
5.1.2.1. Insufficient number of specialized veterinary professionals to adequately address canine arthritis cases
5.1.2.2. Regulatory challenges affecting the approval and availability of novel treatments for canine arthritis
5.1.3. Opportunities
5.1.3.1. Specialized canine arthritis treatment centers offering holistic and integrative medical approaches
5.1.3.2. Subscription-based delivery of joint supplements and pain relief medications for arthritic dogs
5.1.3.3. Wearable technology for continuous monitoring and management of arthritis symptoms in dogs
5.1.4. Challenges
5.1.4.1. High costs associated with veterinary care and arthritis treatments leading to reduced market accessibility
5.1.4.2. Lack of awareness and education among pet owners about early signs and preventive care for canine arthritis
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Canine Arthritis Market, by Product Type
6.1. Introduction
6.2. Assistive Devices and Joint Support
6.2.1. Braces
6.2.2. Harnesses
6.2.3. Other Assistive Devices
6.3. Disease-Modifying Osteoarthritis Drugs (DMOADs)
6.3.1. Structure-Modifying DMOADs
6.3.2. Symptomatic DMOADs
6.4. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
6.4.1. Over-the-Counter NSAIDs
6.4.2. Prescription NSAIDs
6.5. Pain Management Drugs
6.5.1. Opioids
6.5.2. Other Pain Management Drugs
6.5.3. Steroids
6.6. Surgical Treatments
6.6.1. Arthroscopic Surgery
6.6.2. Joint Replacement Surgery
6.6.3. Other Surgical Treatments
7. Canine Arthritis Market, by Route of Administration
7.1. Introduction
7.2. Injectable
7.3. Oral
7.4. Topical
8. Canine Arthritis Market, by End User
8.1. Introduction
8.2. Online Pharmacies
8.3. Retail Pharmacies
8.4. Veterinary Hospitals and Clinics
9. Canine Arthritis Market, by Therapy Type
9.1. Introduction
9.2. Drug Therapy
9.3. Physical Therapy
9.3.1. Acupuncture
9.3.2. Hydrotherapy
9.3.3. Laser Therapy
9.3.4. Other Physical Therapies
9.4. Surgical Therapy
10. Americas Canine Arthritis Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Canine Arthritis Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Canine Arthritis Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.4. Strategy Analysis & Recommendation
LIST OF FIGURES
FIGURE 1. CANINE ARTHRITIS MARKET RESEARCH PROCESS
FIGURE 2. CANINE ARTHRITIS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL CANINE ARTHRITIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
FIGURE 9. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 11. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY THERAPY TYPE, 2023 VS 2030 (%)
FIGURE 13. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY THERAPY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 15. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 17. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. ASIA-PACIFIC CANINE ARTHRITIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. ASIA-PACIFIC CANINE ARTHRITIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CANINE ARTHRITIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CANINE ARTHRITIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. CANINE ARTHRITIS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 23. CANINE ARTHRITIS MARKET, FPNV POSITIONING MATRIX, 2023
LIST OF TABLES
TABLE 1. CANINE ARTHRITIS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL CANINE ARTHRITIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. CANINE ARTHRITIS MARKET DYNAMICS
TABLE 7. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY ASSISTIVE DEVICES AND JOINT SUPPORT, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY BRACES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY HARNESSES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY OTHER ASSISTIVE DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY ASSISTIVE DEVICES AND JOINT SUPPORT, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY DISEASE-MODIFYING OSTEOARTHRITIS DRUGS (DMOADS), BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY STRUCTURE-MODIFYING DMOADS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY SYMPTOMATIC DMOADS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY DISEASE-MODIFYING OSTEOARTHRITIS DRUGS (DMOADS), 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY OVER-THE-COUNTER NSAIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY PRESCRIPTION NSAIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY PAIN MANAGEMENT DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY OPIOIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY OTHER PAIN MANAGEMENT DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY STEROIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY PAIN MANAGEMENT DRUGS, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY SURGICAL TREATMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY ARTHROSCOPIC SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY JOINT REPLACEMENT SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY OTHER SURGICAL TREATMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY VETERINARY HOSPITALS AND CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY DRUG THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY ACUPUNCTURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY HYDROTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY LASER THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY OTHER PHYSICAL THERAPIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY SURGICAL THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY ASSISTIVE DEVICES AND JOINT SUPPORT, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY DISEASE-MODIFYING OSTEOARTHRITIS DRUGS (DMOADS), 2018-2030 (USD MILLION)
TABLE 51. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2030 (USD MILLION)
TABLE 52. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY PAIN MANAGEMENT DRUGS, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 59. ARGENTINA CANINE ARTHRITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 60. ARGENTINA CANINE ARTHRITIS MARKET SIZE, BY ASSISTIVE DEVICES AND JOINT SUPPORT, 2018-2030 (USD MILLION)
TABLE 61. ARGENTINA CANINE ARTHRITIS MARKET SIZE, BY DISEASE-MODIFYING OSTEOARTHRITIS DRUGS (DMOADS), 2018-2030 (USD MILLION)
TABLE 62. ARGENTINA CANINE ARTHRITIS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2030 (USD MILLION)
TABLE 63. ARGENTINA CANINE ARTHRITIS MARKET SIZE, BY PAIN MANAGEMENT DRUGS, 2018-2030 (USD MILLION)
TABLE 64. ARGENTINA CANINE ARTHRITIS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 65. ARGENTINA CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 66. ARGENTINA CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 67. ARGENTINA CANINE ARTHRITIS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 68. ARGENTINA CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 69. BRAZIL CANINE ARTHRITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 70. BRAZIL CANINE ARTHRITIS MARKET SIZE, BY ASSISTIVE DEVICES AND JOINT SUPPORT, 2018-2030 (USD MILLION)
TABLE 71. BRAZIL CANINE ARTHRITIS MARKET SIZE, BY DISEASE-MODIFYING OSTEOARTHRITIS DRUGS (DMOADS), 2018-2030 (USD MILLION)
TABLE 72. BRAZIL CANINE ARTHRITIS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2030 (USD MILLION)
TABLE 73. BRAZIL CANINE ARTHRITIS MARKET SIZE, BY PAIN MANAGEMENT DRUGS, 2018-2030 (USD MILLION)
TABLE 74. BRAZIL CANINE ARTHRITIS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 75. BRAZIL CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 76. BRAZIL CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 77. BRAZIL CANINE ARTHRITIS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 78. BRAZIL CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 79. CANADA CANINE ARTHRITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 80. CANADA CANINE ARTHRITIS MARKET SIZE, BY ASSISTIVE DEVICES AND JOINT SUPPORT, 2018-2030 (USD MILLION)
TABLE 81. CANADA CANINE ARTHRITIS MARKET SIZE, BY DISEASE-MODIFYING OSTEOARTHRITIS DRUGS (DMOADS), 2018-2030 (USD MILLION)
TABLE 82. CANADA CANINE ARTHRITIS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2030 (USD MILLION)
TABLE 83. CANADA CANINE ARTHRITIS MARKET SIZE, BY PAIN MANAGEMENT DRUGS, 2018-2030 (USD MILLION)
TABLE 84. CANADA CANINE ARTHRITIS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 85. CANADA CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 86. CANADA CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 87. CANADA CANINE ARTHRITIS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 88. CANADA CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 89. MEXICO CANINE ARTHRITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 90. MEXICO CANINE ARTHRITIS MARKET SIZE, BY ASSISTIVE DEVICES AND JOINT SUPPORT, 2018-2030 (USD MILLION)
TABLE 91. MEXICO CANINE ARTHRITIS MARKET SIZE, BY DISEASE-MODIFYING OSTEOARTHRITIS DRUGS (DMOADS), 2018-2030 (USD MILLION)
TABLE 92. MEXICO CANINE ARTHRITIS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2030 (USD MILLION)
TABLE 93. MEXICO CANINE ARTHRITIS MARKET SIZE, BY PAIN MANAGEMENT DRUGS, 2018-2030 (USD MILLION)
TABLE 94. MEXICO CANINE ARTHRITIS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 95. MEXICO CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 96. MEXICO CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 97. MEXICO CANINE ARTHRITIS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 98. MEXICO CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 99. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 100. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY ASSISTIVE DEVICES AND JOINT SUPPORT, 2018-2030 (USD MILLION)
TABLE 101. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY DISEASE-MODIFYING OSTEOARTHRITIS DRUGS (DMOADS), 2018-2030 (USD MILLION)
TABLE 102. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2030 (USD MILLION)
TABLE 103. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY PAIN MANAGEMENT DRUGS, 2018-2030 (USD MILLION)
TABLE 104. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 105. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 106. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 107. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 108. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 109. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 110. ASIA-PACIFIC CANINE ARTHRITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 111. ASIA-PACIFIC CANINE ARTHRITIS MARKET SIZE, BY ASSISTIVE DEVICES AND JOINT SUPPORT, 2018-2030 (USD MILLION)
TABLE 112. ASIA-PACIFIC CANINE ARTHRITIS MARKET SIZE, BY DISEASE-MODIFYING OSTEOARTHRITIS DRUGS (DMOADS), 2018-2030 (USD MILLION)
TABLE 113. ASIA-PACIFIC CANINE ARTHRITIS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2030 (USD MILLION)
TABLE 114. ASIA-PACIFIC CANINE ARTHRITIS MARKET SIZE, BY PAIN MANAGEMENT DRUGS, 2018-2030 (USD MILLION)
TABLE 115. ASIA-PACIFIC CANINE ARTHRITIS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 116. ASIA-PACIFIC CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 117. ASIA-PACIFIC CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 118. ASIA-PACIFIC CANINE ARTHRITIS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 119. ASIA-PACIFIC CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 120. ASIA-PACIFIC CANINE ARTHRITIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 121. AUSTRALIA CANINE ARTHRITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 122. AUSTRALIA CANINE ARTHRITIS MARKET SIZE, BY ASSISTIVE DEVICES AND JOINT SUPPORT, 2018-2030 (USD MILLION)
TABLE 123. AUSTRALIA CANINE ARTHRITIS MARKET SIZE, BY DISEASE-MODIFYING OSTEOARTHRITIS DRUGS (DMOADS), 2018-2030 (USD MILLION)
TABLE 124. AUSTRALIA CANINE ARTHRITIS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2030 (USD MILLION)
TABLE 125. AUSTRALIA CANINE ARTHRITIS MARKET SIZE, BY PAIN MANAGEMENT DRUGS, 2018-2030 (USD MILLION)
TABLE 126. AUSTRALIA CANINE ARTHRITIS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 127. AUSTRALIA CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 128. AUSTRALIA CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 129. AUSTRALIA CANINE ARTHRITIS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 130. AUSTRALIA CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 131. CHINA CANINE ARTHRITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 132. CHINA CANINE ARTHRITIS MARKET SIZE, BY ASSISTIVE DEVICES AND JOINT SUPPORT, 2018-2030 (USD MILLION)
TABLE 133. CHINA CANINE ARTHRITIS MARKET SIZE, BY DISEASE-MODIFYING OSTEOARTHRITIS DRUGS (DMOADS), 2018-2030 (USD MILLION)
TABLE 134. CHINA CANINE ARTHRITIS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2030 (USD MILLION)
TABLE 135. CHINA CANINE ARTHRITIS MARKET SIZE, BY PAIN MANAGEMENT DRUGS, 2018-2030 (USD MILLION)
TABLE 136. CHINA CANINE ARTHRITIS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 137. CHINA CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 138. CHINA CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 139. CHINA CANINE ARTHRITIS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 140. CHINA CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 141. INDIA CANINE ARTHRITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 142. INDIA CANINE ARTHRITIS MARKET SIZE, BY ASSISTIVE DEVICES AND JOINT SUPPORT, 2018-2030 (USD MILLION)
TABLE 143. INDIA CANINE ARTHRITIS MARKET SIZE, BY DISEASE-MODIFYING OSTEOARTHRITIS DRUGS (DMOADS), 2018-2030 (USD MILLION)
TABLE 144. INDIA CANINE ARTHRITIS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2030 (USD MILLION)
TABLE 145. INDIA CANINE ARTHRITIS MARKET SIZE, BY PAIN MANAGEMENT DRUGS, 2018-2030 (USD MILLION)
TABLE 146. INDIA CANINE ARTHRITIS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 147. INDIA CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 148. INDIA CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 149. INDIA CANINE ARTHRITIS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 150. INDIA CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 151. INDONESIA CANINE ARTHRITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 152. INDONESIA CANINE ARTHRITIS MARKET SIZE, BY ASSISTIVE DEVICES AND JOINT SUPPORT, 2018-2030 (USD MILLION)
TABLE 153. INDONESIA CANINE ARTHRITIS MARKET SIZE, BY DISEASE-MODIFYING OSTEOARTHRITIS DRUGS (DMOADS), 2018-2030 (USD MILLION)
TABLE 154. INDONESIA CANINE ARTHRITIS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2030 (USD MILLION)
TABLE 155. INDONESIA CANINE ARTHRITIS MARKET SIZE, BY PAIN MANAGEMENT DRUGS, 2018-2030 (USD MILLION)
TABLE 156. INDONESIA CANINE ARTHRITIS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 157. INDONESIA CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 158. INDONESIA CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 159. INDONESIA CANINE ARTHRITIS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 160. INDONESIA CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 161. JAPAN CANINE ARTHRITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 162. JAPAN CANINE ARTHRITIS MARKET SIZE, BY ASSISTIVE DEVICES AND JOINT SUPPORT, 2018-2030 (USD MILLION)
TABLE 163. JAPAN CANINE ARTHRITIS MARKET SIZE, BY DISEASE-MODIFYING OSTEOARTHRITIS DRUGS (DMOADS), 2018-2030 (USD MILLION)
TABLE 164. JAPAN CANINE ARTHRITIS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2030 (USD MILLION)
TABLE 165. JAPAN CANINE ARTHRITIS MARKET SIZE, BY PAIN MANAGEMENT DRUGS, 2018-2030 (USD MILLION)
TABLE 166. JAPAN CANINE ARTHRITIS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 167. JAPAN CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 168. JAPAN CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 169. JAPAN CANINE ARTHRITIS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 170. JAPAN CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 171. MALAYSIA CANINE ARTHRITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 172. MALAYSIA CANINE ARTHRITIS MARKET SIZE, BY ASSISTIVE DEVICES AND JOINT SUPPORT, 2018-2030 (USD MILLION)
TABLE 173. MALAYSIA CANINE ARTHRITIS MARKET SIZE, BY DISEASE-MODIFYING OSTEOARTHRITIS DRUGS (DMOADS), 2018-2030 (USD MILLION)
TABLE 174. MALAYSIA CANINE ARTHRITIS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2030 (USD MILLION)
TABLE 175. MALAYSIA CANINE ARTHRITIS MARKET SIZE, BY PAIN MANAGEMENT DRUGS, 2018-2030 (USD MILLION)
TABLE 176. MALAYSIA CANINE ARTHRITIS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 177. MALAYSIA CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 178. MALAYSIA CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 179. MALAYSIA CANINE ARTHRITIS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 180. MALAYSIA CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 181. PHILIPPINES CANINE ARTHRITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 182. PHILIPPINES CANINE ARTHRITIS MARKET SIZE, BY ASSISTIVE DEVICES AND JOINT SUPPORT, 2018-2030 (USD MILLION)
TABLE 183. PHILIPPINES CANINE ARTHRITIS MARKET SIZE, BY DISEASE-MODIFYING OSTEOARTHRITIS DRUGS (DMOADS), 2018-2030 (USD MILLION)
TABLE 184. PHILIPPINES CANINE ARTHRITIS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2030 (USD MILLION)
TABLE 185. PHILIPPINES CANINE ARTHRITIS MARKET SIZE, BY PAIN MANAGEMENT DRUGS, 2018-2030 (USD MILLION)
TABLE 186. PHILIPPINES CANINE ARTHRITIS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 187. PHILIPPINES CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 188. PHILIPPINES CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 189. PHILIPPINES CANINE ARTHRITIS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 190. PHILIPPINES CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 191. SINGAPORE CANINE ARTHRITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 192. SINGAPORE CANINE ARTHRITIS MARKET SIZE, BY ASSISTIVE DEVICES AND JOINT SUPPORT, 2018-2030 (USD MILLION)
TABLE 193. SINGAPORE CANINE ARTHRITIS MARKET SIZE, BY DISEASE-MODIFYING OSTEOARTHRITIS DRUGS (DMOADS), 2018-2030 (USD MILLION)
TABLE 194. SINGAPORE CANINE ARTHRITIS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2030 (USD MILLION)
TABLE 195. SINGAPORE CANINE ARTHRITIS MARKET SIZE, BY PAIN MANAGEMENT DRUGS, 2018-2030 (USD MILLION)
TABLE 196. SINGAPORE CANINE ARTHRITIS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 197. SINGAPORE CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 198. SINGAPORE CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 199. SINGAPORE CANINE ARTHRITIS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 200. SINGAPORE CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 201. SOUTH KOREA CANINE ARTHRITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 202. SOUTH KOREA CANINE ARTHRITIS MARKET SIZE, BY ASSISTIVE DEVICES AND JOINT SUPPORT, 2018-2030 (USD MILLION)
TABLE 203. SOUTH KOREA CANINE ARTHRITIS MARKET SIZE, BY DISEASE-MODIFYING OSTEOARTHRITIS DRUGS (DMOADS), 2018-2030 (USD MILLION)
TABLE 204. SOUTH KOREA CANINE ARTHRITIS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2030 (USD MILLION)
TABLE 205. SOUTH KOREA CANINE ARTHRITIS MARKET SIZE, BY PAIN MANAGEMENT DRUGS, 2018-2030 (USD MILLION)
TABLE 206. SOUTH KOREA CANINE ARTHRITIS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 207. SOUTH KOREA CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 208. SOUTH KOREA CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 209. SOUTH KOREA CANINE ARTHRITIS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 210. SOUTH KOREA CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 211. TAIWAN CANINE ARTHRITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 212. TAIWAN CANINE ARTHRITIS MARKET SIZE, BY ASSISTIVE DEVICES AND JOINT SUPPORT, 2018-2030 (USD MILLION)
TABLE 213. TAIWAN CANINE ARTHRITIS MARKET SIZE, BY DISEASE-MODIFYING OSTEOARTHRITIS DRUGS (DMOADS), 2018-2030 (USD MILLION)
TABLE 214. TAIWAN CANINE ARTHRITIS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2030 (USD MILLION)
TABLE 215. TAIWAN CANINE ARTHRITIS MARKET SIZE, BY PAIN MANAGEMENT DRUGS, 2018-2030 (USD MILLION)
TABLE 216. TAIWAN CANINE ARTHRITIS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 217. TAIWAN CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 218. TAIWAN CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 219. TAIWAN CANINE ARTHRITIS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 220. TAIWAN CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 221. THAILAND CANINE ARTHRITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 222. THAILAND CANINE ARTHRITIS MARKET SIZE, BY ASSISTIVE DEVICES AND JOINT SUPPORT, 2018-2030 (USD MILLION)
TABLE 223. THAILAND CANINE ARTHRITIS MARKET SIZE, BY DISEASE-MODIFYING OSTEOARTHRITIS DRUGS (DMOADS), 2018-2030 (USD MILLION)
TABLE 224. THAILAND CANINE ARTHRITIS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2030 (USD MILLION)
TABLE 225. THAILAND CANINE ARTHRITIS MARKET SIZE, BY PAIN MANAGEMENT DRUGS, 2018-2030 (USD MILLION)
TABLE 226. THAILAND CANINE ARTHRITIS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 227. THAILAND CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 228. THAILAND CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 229. THAILAND CANINE ARTHRITIS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 230. THAILAND CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 231. VIETNAM CANINE ARTHRITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 232. VIETNAM CANINE ARTHRITIS MARKET SIZE, BY ASSISTIVE DEVICES AND JOINT SUPPORT, 2018-2030 (USD MILLION)
TABLE 233. VIETNAM CANINE ARTHRITIS MARKET SIZE, BY DISEASE-MODIFYING OSTEOARTHRITIS DRUGS (DMOADS), 2018-2030 (USD MILLION)
TABLE 234. VIETNAM CANINE ARTHRITIS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2030 (USD MILLION)
TABLE 235. VIETNAM CANINE ARTHRITIS MARKET SIZE, BY PAIN MANAGEMENT DRUGS, 2018-2030 (USD MILLION)
TABLE 236. VIETNAM CANINE ARTHRITIS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 237. VIETNAM CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 238. VIETNAM CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 239. VIETNAM CANINE ARTHRITIS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 240. VIETNAM CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA CANINE ARTHRITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA CANINE ARTHRITIS MARKET SIZE, BY ASSISTIVE DEVICES AND JOINT SUPPORT, 2018-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA CANINE ARTHRITIS MARKET SIZE, BY DISEASE-MODIFYING OSTEOARTHRITIS DRUGS (DMOADS), 2018-2030 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA CANINE ARTHRITIS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA CANINE ARTHRITIS MARKET SIZE, BY PAIN MANAGEMENT DRUGS, 2018-2030 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA CANINE ARTHRITIS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA CANINE ARTHRITIS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA CANINE ARTHRITIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 252. DENMARK CANINE ARTHRITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 253. DENMARK CANINE ARTHRITIS MARKET SIZE, BY ASSISTIVE DEVICES AND JOINT SUPPORT, 2018-2030 (USD MILLION)
TABLE 254. DENMARK CANINE ARTHRITIS MARKET SIZE, BY DISEASE-MODIFYING OSTEOARTHRITIS DRUGS (DMOADS), 2018-2030 (USD MILLION)
TABLE 255. DENMARK CANINE ARTHRITIS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2030 (USD MILLION)
TABLE 256. DENMARK CANINE ARTHRITIS MARKET SIZE, BY PAIN MANAGEMENT DRUGS, 2018-2030 (USD MILLION)
TABLE 257. DENMARK CANINE ARTHRITIS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 258. DENMARK CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 259. DENMARK CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 260. DENMARK CANINE ARTHRITIS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 261. DENMARK CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 262. EGYPT CANINE ARTHRITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 263. EGYPT CANINE ARTHRITIS MARKET SIZE, BY ASSISTIVE DEVICES AND JOINT SUPPORT, 2018-2030 (USD MILLION)
TABLE 264. EGYPT CANINE ARTHRITIS MARKET SIZE, BY DISEASE-MODIFYING OSTEOARTHRITIS DRUGS (DMOADS), 2018-2030 (USD MILLION)
TABLE 265. EGYPT CANINE ARTHRITIS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2030 (USD MILLION)
TABLE 266. EGYPT CANINE ARTHRITIS MARKET SIZE, BY PAIN MANAGEMENT DRUGS, 2018-2030 (USD MILLION)
TABLE 267. EGYPT CANINE ARTHRITIS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 268. EGYPT CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 269. EGYPT CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 270. EGYPT CANINE ARTHRITIS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 271. EGYPT CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 272. FINLAND CANINE ARTHRITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 273. FINLAND CANINE ARTHRITIS MARKET SIZE, BY ASSISTIVE DEVICES AND JOINT SUPPORT, 2018-2030 (USD MILLION)
TABLE 274. FINLAND CANINE ARTHRITIS MARKET SIZE, BY DISEASE-MODIFYING OSTEOARTHRITIS DRUGS (DMOADS), 2018-2030 (USD MILLION)
TABLE 275. FINLAND CANINE ARTHRITIS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2030 (USD MILLION)
TABLE 276. FINLAND CANINE ARTHRITIS MARKET SIZE, BY PAIN MANAGEMENT DRUGS, 2018-2030 (USD MILLION)
TABLE 277. FINLAND CANINE ARTHRITIS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 278. FINLAND CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 279. FINLAND CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 280. FINLAND CANINE ARTHRITIS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 281. FINLAND CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 282. FRANCE CANINE ARTHRITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 283. FRANCE CANINE ARTHRITIS MARKET SIZE, BY ASSISTIVE DEVICES AND JOINT SUPPORT, 2018-2030 (USD MILLION)
TABLE 284. FRANCE CANINE ARTHRITIS MARKET SIZE, BY DISEASE-MODIFYING OSTEOARTHRITIS DRUGS (DMOADS), 2018-2030 (USD MILLION)
TABLE 285. FRANCE CANINE ARTHRITIS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2030 (USD MILLION)
TABLE 286. FRANCE CANINE ARTHRITIS MARKET SIZE, BY PAIN MANAGEMENT DRUGS, 2018-2030 (USD MILLION)
TABLE 287. FRANCE CANINE ARTHRITIS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 288. FRANCE CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 289. FRANCE CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 290. FRANCE CANINE ARTHRITIS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 291. FRANCE CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 292. GERMANY CANINE ARTHRITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 293. GERMANY CANINE ARTHRITIS MARKET SIZE, BY ASSISTIVE DEVICES AND JOINT SUPPORT, 2018-2030 (USD MILLION)
TABLE 294. GERMANY CANINE ARTHRITIS MARKET SIZE, BY DISEASE-MODIFYING OSTEOARTHRITIS DRUGS (DMOADS), 2018-2030 (USD MILLION)
TABLE 295. GERMANY CANINE ARTHRITIS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2030 (USD MILLION)
TABLE 296. GERMANY CANINE ARTHRITIS MARKET SIZE, BY PAIN MANAGEMENT DRUGS, 2018-2030 (USD MILLION)
TABLE 297. GERMANY CANINE ARTHRITIS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 298. GERMANY CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 299. GERMANY CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 300. GERMANY CANINE ARTHRITIS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 301. GERMANY CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 302. ISRAEL CANINE ARTHRITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 303. ISRAEL CANINE ARTHRITIS MARKET SIZE, BY ASSISTIVE DEVICES AND JOINT SUPPORT, 2018-2030 (USD MILLION)
TABLE 304. ISRAEL CANINE ARTHRITIS MARKET SIZE, BY DISEASE-MODIFYING OSTEOARTHRITIS DRUGS (DMOADS), 2018-2030 (USD MILLION)
TABLE 305. ISRAEL CANINE ARTHRITIS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2030 (USD MILLION)
TABLE 306. ISRAEL CANINE ARTHRITIS MARKET SIZE, BY PAIN MANAGEMENT DRUGS, 2018-2030 (USD MILLION)
TABLE 307. ISRAEL CANINE ARTHRITIS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 308. ISRAEL CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 309. ISRAEL CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 310. ISRAEL CANINE ARTHRITIS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 311. ISRAEL CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 312. ITALY CANINE ARTHRITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 313. ITALY CANINE ARTHRITIS MARKET SIZE, BY ASSISTIVE DEVICES AND JOINT SUPPORT, 2018-2030 (USD MILLION)
TABLE 314. ITALY CANINE ARTHRITIS MARKET SIZE, BY DISEASE-MODIFYING OSTEOARTHRITIS DRUGS (DMOADS), 2018-2030 (USD MILLION)
TABLE 315. ITALY CANINE ARTHRITIS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2030 (USD MILLION)
TABLE 316. ITALY CANINE ARTHRITIS MARKET SIZE, BY PAIN MANAGEMENT DRUGS, 2018-2030 (USD MILLION)
TABLE 317. ITALY CANINE ARTHRITIS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 318. ITALY CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 319. ITALY CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 320. ITALY CANINE ARTHRITIS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)

Companies Mentioned

The leading players in the Canine Arthritis market, which are profiled in this report, include:
  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • Ceva Santé Animale
  • Dechra Pharmaceuticals PLC
  • Elanco Animal Health Incorporated
  • Merck Animal Health
  • Nutramax Laboratories, Inc.
  • Vetoquinol S.A.
  • Virbac
  • Zoetis Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages191
PublishedOctober 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 1.92 Billion
Forecasted Market Value ( USD ) by 2030 $ 3.08 Billion
Compound Annual Growth Rate7.8%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Canine Arthritis Treatment Global Market Report 2024 - Product Image

Canine Arthritis Treatment Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Drug Therapy for Infectious Diseases of the Dog and Cat. Edition No. 1 - Product Image

Drug Therapy for Infectious Diseases of the Dog and Cat. Edition No. 1

  • Book
  • 328 Pages
Animal Vaccines Market by Product, Animal Type - Global Forecast 2025-2030 - Product Image

Animal Vaccines Market by Product, Animal Type - Global Forecast 2025-2030

  • Report
  • 182 Pages
  • Global
From
Veterinary Autoimmune Disease Therapeutics Global Market Report 2024 - Product Image

Veterinary Autoimmune Disease Therapeutics Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Veterinary Vaccines - Global Strategic Business Report - Product Image

Veterinary Vaccines - Global Strategic Business Report

  • Report
  • 263 Pages
  • Global
From

About the Canine Arthritis Drugs Market

The Canine Arthritis Drugs market is a segment of the Animal Pharmaceuticals industry that focuses on providing medications to treat arthritis in dogs. These drugs are typically used to reduce inflammation and pain, as well as to slow the progression of the disease. Commonly used drugs include non-steroidal anti-inflammatory drugs (NSAIDs), corticosteroids, and disease-modifying antirheumatic drugs (DMARDs). In addition, supplements such as glucosamine and chondroitin are often used to help manage the symptoms of arthritis. The Canine Arthritis Drugs market is highly competitive, with a number of companies offering products to treat the condition. Some of the major players in the market include Zoetis, Elanco, Merck Animal Health, Bayer Animal Health, and Ceva Animal Health. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.